Daily Market Insights

Transcription

1 Daily Market Insights 27 th March 2018 Market Snippet H61590 S`4321 Domestic bourses registered strong gains on the account of reports of easing trade war fears between US and China. Gains in European stocks and recovery in Asian shares boosted strong gains on Indices. The sensex settled above the and Nifty above Mark. than Media sector were the major gainers and IT sector were the major losers. Nifty Global Markets Update Equities market from Europe started the week on bullish note with better opening as the fear of trade war eases between China and US.DAX closed higher by 0.3% and STOXX 600 by 0.2%. Bank of New York Mellon Corp increased its position in shares of Five Below Inc by 0.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. INDEX ADVANCE DECLINE UNCHANGED NSE INDEX ADVANCE DECLINE UNCHANGED BSE Gainers LARGECAP %CHANGE MIDCAP %CHANGE YESBANK +6.35% CANBK % SBIN +5.28% CESC +8.28% ZEEL +3.62% ADANIENT +7.41% BAJFINANCE +3.51% UNIONBANK +4.89% TATASTEEL +3.44% BATAINDIA +4.77% Losers LARGECAP %CHANGE MID CAP %CHANGE WIPRO -3.51% VAKRANGEE -5.00% GAIL -3.43% PETRONET -2.63% HINDPETRO -1.47% OIL -2.14% INFY -1.03% MINDTREE -1.39% BOSCHLTD -0.70% OFSS -1.28% Indian Markets INDEX VALUE CHANGE %CHANGE NIFTY % SENSEX % NIFTYBANK % INDIA VIX % International Markets INDEX VALUE CHANGE %CHANGE DOW % NASDAQ % FTSE % SHANGHAI % NIKKEI % Intraday super stars OUR PREVIOUS CALLS UPDATE Date Stocks Entry Exit P/L 26/03 RELIANCE(S) 886 UNEX 26/03 SUNTV(S) 490 UNEX Multibagger Date Stock Entry Exit P/L 26/03 EQUITAS(L) Trifid special Date Stock Entry Exit P/L 26/03 JUBLIANT(L) OPEN For our next calls click here.

2 Stock Snippets Dr Reddy s Laboratories, which is approved by the US Food and Drug Administration (USFDA) has launched Palonosetron Hydrochloride injection, a therapeutic equivalent generic version of ALOXI (palonosetron hydrochloride) injection. On Friday, Reliance Industries made announcement to acquire stake in Saavn to form largest platform of music, media & artists. Technology transfer Agreement signed by BHEL with ISRO for manufacturing of space grade Lithium-ion cells. After getting final approval from the US drug regulator for Metoprolol Succinate extended release tablets, Cadilah Healthcare share prices rose On Monday, JSW Steel Limited announced that it would invest up to $500 million in Texas for expanding its operation as part of memorandum of corporation between Texas Governor s offices and its US unit. The scheme of amalgamation for the merger of Bio Energy Venture 1(Mauritius) Private Limited is approved by Tata Chemicals. Global Markets Asian peers too had a bullish start of the week amid relaxed atmosphere of geopolitical uncertainty as the trade war situation between US and China eases a bit. Japans Nikkei 225 index in Tokyo bounced from six month low and ended 0.7% higher at 20, points. China stocks pared their losses on Monday following the same news and ended higher. Back there in Hong Kong equities reversed the trade as trade war worries eased after reports the United States and China commenced talks to improve U.S. access to Chinese markets. DATE: 26/03/18 FII/DII CASH MTD YTD FII DII Sectoral gainers and losers SECTOR %CHANGE IN ADV DEC MARKETCAP Media & Entertainment 3.04% Retail & Real Estate 2.41% Banking & Financial Services 2.25% Telecommunication 1.74% Metals & Mining 1.55% Automotive 1.48% Miscellaneous 1.43% Consumer Durables 1.36% 8 3 Cement & Construction 1.25% Consumer Nondurables 1.17% Engineering & Capital Goods 0.98% Services 0.91% Chemicals 0.81% Tobacco 0.81% 3 2 Food & Beverages 0.66% Manufacturing 0.64% Pharmaceuticals 0.58% Utilities 0.38% Conglomerates 0.25% Oil & Gas 0.14% Information Technology -0.62% Stocks breakout on moving average STOCKS PRICE 30DMA BATAINDIA UPL HDFCBANK DISHTV

3 Intraday super star calls (Premium Section) APOLLOTYRE EQ showed buying momentum in last two trading session and closed near the consolidation range on daily chart. The stock may give breakout ahead. BUY ABOVE TARGETS /274.90/ SL ASIANPAINT EQ formed bullish hammer candle formation on daily chart with sustainable buy side volume. Thus expected to trade higher ahead too. BUY ABOVE 1124 TARGETS / / SL

4 F&O Multibagger call (Premium Section) UJJIVAN FUT traded northwards and closed near the drawn resistance level. The stock fut may trade higher in coming trade session too. BUY ABOVE TARGETS / SL

5 Trifid Special call (Premium Section) JUBILANT EQ formed bullish engulfing pattern formation on daily chart and ended near the consolidation resistance level. The stock may give breakout ahead. BUY ABOVE TARGETS SL

6 Major Indices Movement Nifty Technical s Nifty recovered loss and traded bullish on account of short covering seen before March F&O expiry. Nifty ended at The next key support and resistance for the market is at and Bank Nifty Technicals Nifty bank too witnessed short covering before expiry and closed 2.50% higher at The next key support and resistance for the banking index is at and respectively. Index 23-March March-18 Change in OI %Chg NIFTY % SCRIPS IN F&O BAN FOR TRADE IFCI, JETAIRWAYS, JPASSOCIAT, ORIENTBANK

7 Up s and Down s Stocks at 52 Week High Stocks New 52 W/H Previous High JUBLFOOD MASKINVEST TITAN Stocks Approaching 52 Week High Stocks LTP 52W High BHARATFIN CHOLAFIN INDUSINDBK TECHM HEXAWARE Stocks rising continuously 2-3 days Stocks LTP RELIANCE JUBLIANT TV18BRDCST PAGEIND Stocks at 52 Week Low Stocks New 52 W/L Previous Low ALLCARGO ASTRON CAPF CENTUM DCM Stocks Approaching 52 Week Low Stocks LTP 52W Low KWALITY ICRA BSE GREAVESCOT Stocks falling continuously 2-3 days Stocks LTP GITANJALI 9.15 HINDPETRO HDIL IFCI Event Calendar(26 th MARCH to 31 st MARCH 18) 26/03/18 (Mon) 27/03/18 (Tues) 28/03/18 (Wed) 29/03/18 (Thur) 30/03/18 (Fri) 31/03/18 (Sat) ECO DATA INFRASTRUCTRE OUTPUT FOREIGN DEBT

8 DISCLAIMER Trifid Research respects and values the Right to Policy of each and every individual. We are esteemed by the relationship and by becoming our clients; you have a promise from our side that we shall remain loyal to all our clients and non-clients whose information resides with us. This Privacy Policy of Trifid Research applies to the current clients as well as former clients. Below are the word by word credentials of our Privacy Policy: 1. Your information, whether public or private, will not be sold, rented, exchanged, transferred or given to any company or individual for any reason without your consent. 2. The only use we will be bringing to your information will be for providing the services to you for which you have subscribed to us. 3. Your information given to us represents your identity with us. If any changes are brought in any of the fields of which you have provided us the information, you shall bring it to our notice by either calling us or dropping a mail to us. 4. In addition to the service provided to you, your information (mobile number, ID etc.) can be brought in use for sending you newsletters, surveys, contest information, or information about any new services of the company which will be for your benefit and while subscribing for our services, you agree that Trifid Research has the right to do so. 5. By subscribing to our services, you consent to our Privacy Policy and Terms of Use. 6. Trifid research does not guarantee or is responsible in any which way, for the trade execution of our recommendations, this is the sole responsibility of the client. 7. Due to the market s volatile nature, the trader may/ may not get appropriate opportunity to execute the trades at the mentioned prices and Trifid Research hold s no liability for any profit/ loss incurred whatsoever in this case. 8. It is the responsibility of the client to view the report timely from our Premium member section on our website: and the same will also be mailed to this registered id. 9. Trifid research does not hold any liability or responsibility of delay in mail delivery of reports, as this depends on our mail service provider s network infrastructure. 10. The clients can call us for any query related to buying/selling the securities, based on our recommendations.